OBJECTIVE: To evaluate issues pertaining to cochlear implantation in @entity1 with far advanced @entity8719 . STUDY DESIGN: Prospective cohort. SETTING: Tertiary care referral center. @entity1 : Eight adult @entity1 (18 years of age or older) referred for management of profound @entity393 , the cause of which was determined to be @entity8719 . INTERVENTION: Cochlear implantation with multichannel cochlear implant device. MAIN OUTCOME MEASURES: Benefit from cochlear implant as measured by CID sentence scores, incidence and management of facial nerve stimulation, and technical issues pertaining to cochlear implantation in this @entity1 population. RESULTS: All @entity1 demonstrated significant improvement in auditory function as measured by performance on CID sentence scores and ability to engage in telephone conversation. Facial nerve stimulation was present in two of eight @entity1 and was managed with deactivation of the stimulating electrodes. Ossification in the basal turn of the cochlea, detected on preoperative computed tomography, necessitated placement of the electrode into the scala vestibuli in two @entity1 and use of a thinner electrode (Nucleus 24) in a third @entity1 . CONCLUSION: @entity1 with profound @entity393 secondary to @entity8719 derive excellent benefits from cochlear implantation. Surgical implantation may be complicated by ossification of the cochlea, which can be detected on preoperative computed tomography. Electrode activation may be complicated by facial nerve stimulation, which can be addressed with programming strategies.

Management of far advanced XXXX in the era of cochlear implantation.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'PATIENTS'] @entity393 :: ('MESH:D034381', 'Disease') :: ['hearing loss'] @entity8719 :: ('MESH:D010040', 'Disease') :: ['otosclerosis', 'cochlear otosclerosis']
@entity8719 :: (MESH:D010040,Disease) :: ['otosclerosis']
